SageView Advisory Group’s Mesoblast MESO Stock Holding History

SageView Advisory Group’s Portfolio MESO Stock Details MESO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-11	Closed	-$199	–	1689
2025 Q4	$199	Buy	+11	New	+$189	﹤0.01%	2512

Other funds holding MESO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Penbrook Management New York $157M AUM 46.57% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Group One Trading Chicago, Illinois $71.1B AUM 128.96% 1-Year Est. Return

SageView Advisory Group's MESO Position: Q1 2026 in Review

SageView Advisory Group sold out of Mesoblast (MESO) in Q1 2026, closing a stake of 11 shares — an estimated $199 sold.

SageView Advisory Group first reported a position in MESO in Q4 2025 and held it in 1 quarter. The position peaked at $199 in Q4 2025. 69 funds tracked by Wall St. Rank hold MESO as of Q1 2026.

SageView Advisory Group reported no remaining Mesoblast position as of Q1 2026 after selling out during the quarter.
SageView Advisory Group sold 11 Mesoblast shares in Q1 2026, an estimated $199.
SageView Advisory Group first reported a position in Mesoblast in Q4 2025 and held it in 1 quarter.
SageView Advisory Group's Mesoblast position peaked at $199 in Q4 2025.
69 funds tracked by Wall St. Rank held Mesoblast as of Q1 2026.

Based on SageView Advisory Group's 13F filing for Q1 2026, filed 10 Aug 2026.